Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug ...

As Artificial Intelligence becomes more popular in everyday life, drug research and development companies are incorporating it into their process.

Drug development is risky, with most drugs failing in testing, making regulators crucial parties, say regulatory experts and industry officials. But the biotech industry is particularly vulnerable ...

Failure rates remain staggeringly high even with billions of dollars being invested in research and development (R&D). Between 70% and 90% of drug candidates will fail. This can be the result of ...

Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...

That’s why it’s important to develop a strategy for managing health data globally to streamline the drug development process and, in turn, create more effective outcomes for patients.

Biotech companies developing drugs for hard-to-treat diseases and other ailments are being forced to push back clinical trials and drug testing in the wake of mass layoffs at the Food and Drug ...